These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3598064)

  • 1. Influence of antioxidant enzymes in reduction of optic disc edema in experimental optic neuritis.
    Guy J; Ellis EA; Hope GM; Rao NA
    J Free Radic Biol Med; 1986; 2(5-6):349-57. PubMed ID: 3598064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversals of blood-brain barrier disruption by catalase: a serial magnetic resonance imaging study of experimental optic neuritis.
    Guy J; McGorray S; Fitzsimmons J; Beck B; Mancuso A; Rao NA; Hamed L
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3456-65. PubMed ID: 8056521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant enzyme suppression of demyelination in experimental optic neuritis.
    Guy J; Ellis EA; Hope GM; Rao NA
    Curr Eye Res; 1989 May; 8(5):467-77. PubMed ID: 2736952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis.
    Qi X; Hauswirth WW; Guy J
    Mol Vis; 2007 Jan; 13():1-11. PubMed ID: 17242675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis.
    Guy J; McGorray S; Qi X; Fitzsimmons J; Mancuso A; Rao N
    Ophthalmic Res; 1994; 26(5):310-23. PubMed ID: 7533278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
    Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral gene therapy with catalase suppresses experimental optic neuritis.
    Guy J; Qi X; Wang H; Hauswirth WW
    Arch Ophthalmol; 1999 Nov; 117(11):1533-9. PubMed ID: 10565523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis.
    Qi X; Guy J; Nick H; Valentine J; Rao N
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1203-12. PubMed ID: 9152240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant enzymes reduce loss of blood-brain barrier integrity in experimental optic neuritis.
    Guy J; Ellis EA; Hope GM; Rao NA
    Arch Ophthalmol; 1989 Sep; 107(9):1359-63. PubMed ID: 2783067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hydrogen peroxide in experimental optic neuritis. A serial quantitative ultrastructural study.
    Guy J; Ellis EA; Mames R; Rao NA
    Ophthalmic Res; 1993; 25(4):253-64. PubMed ID: 8233351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen peroxide localization in experimental optic neuritis.
    Guy J; Ellis EA; Rao NA
    Arch Ophthalmol; 1990 Nov; 108(11):1614-21. PubMed ID: 2244846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin.
    Guy J; McGorray S; Fitzsimmons J; Beck B; Rao NA
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1114-23. PubMed ID: 8125722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations.
    Hayreh SS; Massanari RM; Yamada T; Hayreh SM
    Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):256-69. PubMed ID: 7251309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis.
    Robin JB; Phillips TM; Rao NA
    Ophthalmic Res; 1985; 17(3):174-80. PubMed ID: 2409498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental allergic optic neuritis in guinea pigs: preliminary report.
    Rao NA; Tso MO; Zimmerman EL
    Invest Ophthalmol Vis Sci; 1977 Apr; 16(4):338-42. PubMed ID: 844991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
    Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis.
    Guo X; Harada C; Namekata K; Kikushima K; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
    Neurosci Lett; 2009 Oct; 462(3):281-5. PubMed ID: 19616065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis.
    Hoffmann DB; Williams SK; Bojcevski J; Müller A; Stadelmann C; Naidoo V; Bahr BA; Diem R; Fairless R
    J Neuropathol Exp Neurol; 2013 Aug; 72(8):745-57. PubMed ID: 23860028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
    Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.